PHD1 regulates p53‐mediated colorectal cancer chemoresistance

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|10|1350-1365

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.10, 2015-10, pp. : 1350-1365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

By  

EMBO Molecular Medicine, Vol. 1757-4676, Iss. 10, 2015-10 ,pp. : 1350-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic inhibition of TRF1 impairs the growth of p53‐deficient K‐RasG12V‐induced lung cancer by induction of telomeric DNA damage

By  

EMBO Molecular Medicine, Vol. 7, Iss. 7, 2015-07 ,pp. : 930-949

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 735-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gallotannin is a DNA damaging compound that induces senescence independently of p53 and p21 in human colon cancer cells

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 1037-1050

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gallotannin is a DNA damaging compound that induces senescence independently of p53 and p21 in human colon cancer cells

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1037-1050

John Wiley & Sons Inc

Access to resources Recommend Favorite